Background: The provisional side-branch intervention strategy remains the gold standard approach for repair of coronary bifurcation lesions. We performed this study to evaluate the clinical and functional outcomes of using the instantaneous wave-free ratio (iFR) for physiological assessment in provisional side-branch repair of bifurcation lesions. Methods: Fifty patients with coronary bifurcation lesions were equally divided into two groups: (I) an iFRguided side-branch intervention group and (II) a conventional group, in which the operator selected a different interventional method. After the procedure, we performed a six-month follow-up for postoperative ejection fraction (EF) and clinical cardiac outcomes. Results: Our results showed that the iFR measurement procedure was technically feasible in bifurcation lesions, with no procedural-related complications. Moreover, measuring iFR significantly predicted the side-branch percent stenosis after stenting of the main branch (r = À0.81, p < 0.0001). Compared to the conventional group, the iFR-guided group showed a significantly shorter procedural time (MD = À14.6 min, 95% CI [À27.7, À1.4]) and hospital stay duration (MD = À0.92 days, 95% CI [À1.6, À0.28]). However, no significant differences were recorded between the iFR-guided and conventional groups in terms of postoperative EF (p = 0.9), six-month heart failure class (p = 0.89), or postinterventional angina (p = 0.066). Conclusion: Using iFR for physiological assessment during the provisional side-branch intervention strategy can reduce the procedural time and length of hospital stay in patients with bifurcation lesions. Larger trials should compare the clinical outcomes of iFR to other physiological assessment methods such as the fractional flow reserve (FFR) in patients with coronary bifurcation lesions. ClinicalTrials.gov number: NCT02785510
Introduction
Despite the remarkable advances in the field of coronary interventions, bifurcation lesions still represent a challenge in interventional cardiology. 1, 2 The difficult anatomical position of these lesions makes their interventions technically demanding with a higher complication rate than non-bifurcation lesions. 3, 4 Because no former study showed an additional clinical benefit for the complex systematic two-stenting procedure, the provisional side-branch intervention strategy remains the gold standard approach for bifurcation lesions repair. 5, 6 During this procedure, the operator needs to decide whether the jailed side-branch needs dilatation and stenting after main-branch stent implantation.
For decades, coronary angiography was the routine diagnostic method for lesion evaluation and decision-making in side-branch interventions. Given the well-documented discordance between angiographic findings and the functional severity of the lesion, 7, 8 the advent of fractional flow reserve (FFR) allowed more accurate assessment of lesion severity. [9] [10] [11] However, FFR guidance showed similar clinical outcomes in comparison to angiography in provisional side-branch interventions. 12 Moreover, the need to administer adenosine to minimize the microvascular resistance for accurate FFR measurement increases the risk of adverse events such as breathlessness, chest tightness, and occasionally severe asthma. 13 Therefore, none of these tools (angiography or FFR) is yet validated for decision making in side-branch interventions. 10 In 2012, Sen and colleagues introduced the instantaneous wavefree ratio (iFR) as an adenosine-independent index of coronary stenosis severity. 14 Several studies, [14] [15] [16] [17] [18] along with a recent metaanalysis, 19 demonstrated a high accuracy for iFR in the evaluation of coronary lesions with FFR as the standard reference. Moreover, two recent large trials (DEFINE-FLAIR and iFR-SWEDEHEART) showed that iFR was non-inferior to FFR with respect to the rate of major adverse cardiac events at 1 year post-intervention. 20, 21 Reviewing the literature, no former study has evaluated the clinical utility of iFR measurement in provisional repair of jailed side-branch lesions. We conducted this study to evaluate the functional aspects of iFR-guided provisional jailed side-branch interventions and compare its clinical endpoints to conventional non-iFR-guided operations.
Materials and methods

Patient selection
The study protocol was approved by the institutional review board of Al-Azhar University. The study was conducted in two centers: The Saudi-German Hospital (Aseer, Abha city, Saudi Arabia) and Aseer Central Hospital (Aseer, Abha, Saudi Arabia) after reviewing the approved protocol. All enrolled patients gave an informed consent after understanding the procedures and the purpose of the study. All procedures in this study were performed in accordance with the Ethical Declaration of Helsinki. All patients were subject to a complete history taking (as regard age, gender, risk factors, previous angina/myocardial infarction, previous percutaneous transluminal coronary angioplasty), full physical and cardiac examination, cardiac enzymes biomarkers (including troponin I and Creatine Kinase-MB) before and after percutaneous coronary intervention (PCI), as well as resting ECG assessment, and transthoracic echocardiography before and after PCI.
IFR-guided side-branch intervention group
Patients with acute coronary syndrome (who were admitted to the coronary care unit) were included if they had a jailed sidebranch (culprit lesion with a bifurcation anatomy) of a vessel size >2 mm, vessel length >40 mm, and an estimated lesion length <10 mm by visual estimation.
Patients were excluded from the study if they had any of the following: a significant stenosis in the left main coronary artery or the main branch proximal to the stented segment, totally ocluded bifurcation lesions, primary myocardial disease, or a serum creatinine level of !2.
Conventional intervention group
The same selection criteria were applied to enroll patients in the conventional group. These patients underwent coronary intervention by operators, not involved in the iFR-guided strategy.
Study procedure
In both groups, culprit lesion severity was judged by multiple views, including orthogonal projections. The culprit lesion severity, Medina bifurcation class and coronary blood flow were assessed by eyeballing, and matching with the American Heart Association classification. 22, 23 Analysis was done by two independent experienced operators. The cut-off value for coronary intervention was a lesion stenosis of !70%. 22 Coronary stenting of the main branch was performed with standard interventional techniques using drug-eluting [zotarolimus] stents. After successful stenting, a reference image was obtained. In the iFR group, pressure measurement was performed using a pressure guide wire [iFR volcano wire]. The wire was passed through the stent struts of the main branch to the sidebranch and the iFR was measured at 5 mm distal to the side-branch ostium to assess the severity of stenosis. The iFR measurements were performed after stabilization of ACS by low molecular weight heparin and antiplatelet medications.
Lesions with an iFR 0.89 [equivalent to an FFR of 0.80] were considered to have a functionally significant stenosis and sidebranch balloon dilatation (using a smaller balloon than the sidebranch vessel diameter) was allowed only for these lesions. After drug-eluting balloon (DEB) inflation [PANTERALUX: Paclitaxel releasing PTCA balloon catheter], the iFR was measured again at the same site and further intervention was only recommended when iFR was 0.89 after DEB inflation.
In the conventional group, the decision to treat the side-branch lesion and the method of intervention were all up to the operators' discretion. Clinical follow-up, as well as angiogrphic follow up in the conventional group, were performed after stent implantation for six months for the following outcomes: Ejection fraction (EF), heart failure, and post-PCI angina.
Statistical analysis
All data were reported as means AE standard deviations (SD) for continuous variables and as a percentages for categorical variables. All data were normally distributed; therefore, the Chi-square and Student's t-tests were used to compare categorical and continuous variables, respectively. Simple linear regression was employed to test the correlation between iFR value and percent stenosis of the jailed side-branch. A difference was considered significant when the p value was <0.05. We used SPSS (Version 22 for Windows) to conduct the statistical analysis.
Results
Fifty patients with bifurcation coronary lesions, categorized according to Medina classification, were consecutively enrolled in this study between March 2014 and January 2017 ( Fig. 1 ). The iFR was successfully measured in 25 patients (iFR group) and the other 25 patients (conventional group) were treated according to the operator's discretion. Age, sex, and body weight were comparable between the two groups (p = 0.18, 1, and 0.74 respectively). Baseline characteristics of enrolled patients are presented in Table 1 .
iFR and percent stenosis values after main branch stenting
Following stenting of the main branch and before DEB inflation in the jailed side-branch, a significant reduction of stenosis in the main branch was observed in both the proximal (Mean Difference [MD] = À59.3%, p < 0.0001) and distal (MD = À44.2%, p < 0.0001) segments and the percent stenosis (pre-stenting = 46.6%, poststenting = 62%, p < 0.0001) was markedly increased in the jailed side-branch (MD = 15.4%, p < 0.0001). Measuring iFR significantly predicted the side-branch percent stenosis after stenting of the main branch (r = À0.81, p < 0.0001).
iFR changes after DEB inflation of the jailed side-branch
DEB inflation was performed in 25 patients in the iFR group. The iFR measurements improved from 0.71 AE 0.19 post-stenting of the main branch to 0.90 AE 0.16 after side-branch balloon inflation (MD = 0.19, p = 0.013). The proportion of patients with functionally significant stenosis after DEB inflation was 4% (1/25) in the iFR group and 12% (3/25) in the conventionally treated cohort (p = 0.32). In the iFR group, mean iFR in the jailed side-branch on follow up was 0.84 AE 0.19. Fig. 2 shows the changes in the iFR measurements after the procedure and during follow up.
Comparison of clinical outcomes, procedural time and hospital stay duration between the iFR and conventional groups
The iFR group was superior to the conventional group in terms of shortening the length of hospital stay (MD = À0.92 days, 95% CI [À1.6 to À0.28], p = 0.006), procedural time (MD = À14.6 min, 95% CI [À27.7 to À1.4], p = 0.03), and fluoroscopy time (MD = À9.3 min, 95% CI [-18 to À5.2], p = 0.038). The amount of dye injection for angiography was significantly less in the iFR group (p = 0.03), compared to the conventional group.
In terms of EF, no significant difference in the conventional group was noted before and after the intervention (p = 0.51), while there was a significant improvement in the iFR group after the intervention, compared to baseline EF (p = 0.01). However, EF at 6 months after the procedure was similar in the two groups (p = 0.9). Two myocardial infarction events in the main branch occurred in the conventional group: the first took place following the PCI procedure and the patient died 10 days afterwards, while the second occurred due to late-stent thrombosis (corrected by target vessel revascularization). There was no difference between both groups with regard to the in-hospital heart failure class (p = 0.36), six-month heart failure class (p = 0.89), and post-PCI angina (p = 0.066). A summary of the results of clinical outcomes is illustrated in Table 2 .
Discussion
Over the past 20 years, several physiological measurements were developed to guide coronary revascularization, of which the FFR was the most promising. Measuring FFR relies primarily on the directly proportional relationship between flow and pressure under conditions of constant and minimal intracoronary resistance. 24 To overcome the phasic pattern in which the intracoronary resistance changes over the cardiac cycle, the FFR is measured during hyperemia (using adenosine) and timeaveraged over multiple cardiac cycles (using computational methods).
Although the 2009 Focused Updates of the ACC/AHA/SCAI guidelines on PCI upgraded the level of evidence on FFR to "A" level, 25 its use remains restricted globally due to: 1) the lack of device reimbursement in several countries, [26] [27] [28] 2) multiple side effects and contraindications to adenosine administration, and 3) the apparent prolongation of the procedure time. 29 Five years ago (2012), Sen and colleagues calculated iFR as a ratio of transstenotic pressures during a diastolic wave-free period (when resistance is naturally constant and minimal); therefore, avoiding beat-to-beat pressure fluctuations and eliminating the need for adenosine adminstration and advanced computational methods. 14, 17 Our study showed that using iFR for physiological assessment of bifurcation lesions significantly reduced the procedural time (probably related to fluoroscopy time reduction and should be further confirmed), length of hospital stay, and amount of dye needed for angiography. However, we could not detect a significant change in post-operative EF, the number of patients with residual functional stenosis, or postoperative complications including angina or heart failure. The DEFINE-FLAIR study reported a significantly shorter procedural time in the iFR group (p = 0.001), compared to the FFR group. 21 This is unlike the iFR-SWEDEHEART study that reported a non-significant difference (p = 0.09) in procedural time between both groups. 20 The ADVISE II and Härle et al, 15, 16 studies suggested adopting a hybrid of FFR-iFR guidance to enhance the diagnostic accuracy and expose fewer patients to adenosine. In the same vein, the VERIFY II study 30 showed that using the hybrid strategy resulted in 54% less adenosine infusion, yet a misclassification rate of 10% still disregards iFR feasibility. This approach will be further investigated in the ongoing multicenter SYNTAX II trial (NCT02015832), which applies ischemia-driven revascularization to PCI-treated patients with triple vessel disease.
In the recently released (2017) version of the appropriate use criteria for coronary revascularization, both iFR and FFR are recommended for physiological assessment in single and multivessel coronary artery disease. 31, 32 Combined with the formerly mentioned advantages over FFR, we hope that adopting iFR will increase the use of physiological assessment in interventional practice.
According to our hospital protocol, a longer hospital follow up is recommended in patients who receive an additional stent to the side-branch vessel. Following an accurate assessment of the sidebranch lesion severity using iFR, no stents were implanted in the side-branch vessels. Therefore, these patients were discharged early from our hospital, accounting for the shorter hospital stay in the iFR group.
Strength points
Although several studies have assessed the diagnostic utility of iFR in stable coronary stenosis or ACS, our study is the first to specifically investigate this point in bifurcation lesions. Unlike the majority of former studies on iFR, which were primarily focused on the functional and diagnostic accuracy outcomes, our study targeted the identification of the iFR effects on the interventional procedure characteristics and postoperative complications. 
Limitations
Our sample size was relatively small; therefore, our results are suggestive rather than conclusive and need further confirmation in larger clinical trials. Moreover, the bifurcation-repair procedure is primarily dependent on the operator's profissionality and his skills of intervention. We did not directly compare iFR to FFR in bifurcation lesions and this head-to-head comparison is essential before the wide introduction of iFR in clinical practice.
Conclusions
Using the iFR for physiological assessment during the provisional side-branch interventional strategy is feasible and can reduce the procedural time and the length of hospital stay in patients with bifurcation lesions. However, we could not detect a significant improvement of the postoperative EF or cardiac complications. Future trials with larger sample size should directly compare the clinical outcomes of iFR and FFR assessments, especially in patients with coronary bifurcation lesions.
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